These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16814680)

  • 21. [Hemodynamic effects of combined isosorbide dinitrate-nifedipine therapy in congestive heart failure (author's transl)].
    Matsui S; Murakami E; Takekoshi N; Murakami H; Masuya K; Nomura M; Fujita S; Tsuji S; Chadani T
    Kokyu To Junkan; 1981 Sep; 29(9):965-70. PubMed ID: 7323483
    [No Abstract]   [Full Text] [Related]  

  • 22. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 23. Studying treatment of heart failure in blacks.
    Brandt D
    Am J Nurs; 2005 Feb; 105(2):20. PubMed ID: 15674043
    [No Abstract]   [Full Text] [Related]  

  • 24. [Premises on the use of vasodilator agents. The venous or mixed vasodilators].
    Prati PL; Pezzella A; Di Lorenzo M; Barbis V; Manfrin M; Giovannini E; Gambelli G; Signoretti P; Pittorino L; Greco C
    G Ital Cardiol; 1979; 9 Suppl 1():18-20. PubMed ID: 548300
    [No Abstract]   [Full Text] [Related]  

  • 25. [Nitrates in the complex treatment of circulatory failure].
    Karbasnikova GV; Zabel'ian OM; Barbakova AA; Valeeva RM; Zhuikova AA
    Sov Med; 1985; (6):69-73. PubMed ID: 3933124
    [No Abstract]   [Full Text] [Related]  

  • 26. New approaches to the diagnosis and management of acute cardiac failure.
    Mantle JA; Rogers WJ; Papapietro SE; Russell RO; Rackley CE
    Ala J Med Sci; 1981 Jul; 18(3):268-73. PubMed ID: 7283081
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of the vasodilator nitrosorbide in the treatment of chronic heart failure].
    Mareev VIu; Grigor'iants RA; Lobova NM; Naumov VG
    Sov Med; 1983; (1):70-4. PubMed ID: 6836396
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of trekrezan on the lipid peroxidation in patients with chronic cardiac insufficiency].
    Sabadyshin RO; Slipak OIa; Koval'chuk SF; D'iakov VM; Kazimirovskaia VB
    Biull Eksp Biol Med; 1998 Aug; 126(8):186-8. PubMed ID: 9777233
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of isosorbide dinitrate tape (TY-0081) on congestive heart failure: results of multicenter study].
    Niitani H; Takano T; Tanaka K; Hiramori K; Ikeda M; Kimata S
    Kokyu To Junkan; 1984 Aug; 32(8):841-7. PubMed ID: 6393254
    [No Abstract]   [Full Text] [Related]  

  • 30. Eccentric dosage regimen for isosorbide dinitrate.
    Straka RJ; Benson S
    Am Fam Physician; 1997 Jan; 55(1):52, 54, 57. PubMed ID: 9012289
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.
    Howard PA; Cheng JW; Crouch MA; Colucci VJ; Kalus JS; Spinler SA; Munger M
    Ann Pharmacother; 2006 Sep; 40(9):1607-17. PubMed ID: 16896019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coronary insufficiency: symptoms and diagnostic assessment. Causal/symptomatic therapy].
    Lüderitz B; Wagner WL; Manz M
    Verh Dtsch Ges Inn Med; 1990; 96():85-95. PubMed ID: 2092518
    [No Abstract]   [Full Text] [Related]  

  • 33. [Combined use of isoprenaline and hydralazine in the treatment of chronic circulatory insufficiency].
    Krzyś T; Kalawski R; Flaczyński K; Lenartowicz I
    Wiad Lek; 1985 Jan; 38(2):97-101. PubMed ID: 4002707
    [No Abstract]   [Full Text] [Related]  

  • 34. Eccentric dosage regimen for isosorbide dinitrate.
    Glasser SP
    Am Fam Physician; 1997 Jan; 55(1):57-8. PubMed ID: 9012290
    [No Abstract]   [Full Text] [Related]  

  • 35. Eccentric dosage regimen for isosorbide dinitrate.
    Gonzalez ER; Chaponis RJ; Davidson HE
    Am Fam Physician; 1997 Jan; 55(1):58. PubMed ID: 9012291
    [No Abstract]   [Full Text] [Related]  

  • 36. Isosorbide dinitrate spray as therapeutic strategy for treatment of chronic venous ulcers.
    Sánchez-Vázquez R; Briseño-Rodríguez G; Cardona-Muñoz EG; Gálvez-Gastélum FJ; Totsuka-Sutto SE; Garcia-Benavides L
    Angiology; 2008; 59(1):64-71. PubMed ID: 18319224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative effects of a single dose of isosorbide dinitrate by sublingual (10 mg) and oral (20 mg) routes in congestive left heart ventricle failure].
    Daubert JC; Bourdonnec C; Langella B; Gouffault J
    Ann Cardiol Angeiol (Paris); 1982; 31(1):59-65. PubMed ID: 7065626
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of vasodilator treatment of chronic circulatory insufficiency on various polycardiographic parameters].
    Guzińska B; Nartowicz E
    Kardiol Pol; 1983; 26(7):565-70. PubMed ID: 6645153
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
    Franchi F; Michelucci A; Morace G; Porciani MC; Fantini F
    Clin Ter; 1980 Apr; 93(1):3-20. PubMed ID: 7449331
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and haemodynamic assessment of non-parenteral vasodilator treatment in congestive heart failure.
    Gupta MP; Arora AP; Arora R
    Indian Heart J; 1980; 32(5):286-90. PubMed ID: 7239546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.